Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization

Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 94

Oncogenic Ras Induces p19ARF and Growth Arrest in Mouse Embryo Fibroblasts Lacking p21Cip1 and p27Kip1 without Activating Cyclin D-dependent Kinases

Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 92

JNK Regulates Autocrine Expression of TGF-β1

Ventura, J., Kennedy, N. J., Flavell, R. A., & Davis, R. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.007 · Cited by 95

Mnt Loss Triggers Myc Transcription Targets, Proliferation, Apoptosis, and Transformation

Nilsson, J. A., Maclean, K. H., Keller, U. B., Pendeville, H., Baudino, T. A., & Cleveland, J. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1560-1569.2004 · Cited by 91

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis

Arango, D., Mariadason, J. M., Wilson, A. J., Yang, W., Corner, G. A., Nicholas, C., Aranes, M., & Augenlicht, L. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601338 · Cited by 91

Cell Transformation by the E7 Oncoprotein of Human Papillomavirus Type 16: Interactions with Nuclear and Cytoplasmic Target Proteins

Zwerschke, W., & Jansen‐Dürr, P. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)61022-2 · Cited by 92

Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer

Amir, S., Ma, A., Shi, X.-B., Xue, L., Kung, H.-J., & White, R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061064 · Cited by 90

p19Arf-p53 Tumor Suppressor Pathway Regulates Cell Motility by Suppression of Phosphoinositide 3-Kinase and Rac1 GTPase Activities

Guo, F., Gao, Y., Wang, L., & Zheng, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300341200 · Cited by 90

Regulation and activation of p53 and its family members

Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91

Human ARF protein interacts with Topoisomerase I and stimulates its activity

Karayan, L., Riou, J., Seité, P., Migeon, J., Cantereau, A., & Larsen, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204170 · Cited by 89

Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors

Zheng, S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.2057 · Cited by 89

A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.

Zhu, J. W., DeRyckere, D., Li, F. X., Wan, Y. Y., & DeGregori, J. V. (1999) · PubMed · Cited by 89

E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines

Kitagawa, M., Aonuma, M., Lee, S. H., Fukutake, S., & McCormick, F. P. (2008) · Oncogene · doi:10.1038/onc.2008.164 · Cited by 89

Cellular Senescence in the Development and Treatment of Cancer

Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 92

The Methyltransferase Set7/9 (Setd7) Is Dispensable for the p53-Mediated DNA Damage Response In Vivo

Campaner, S., Spreafico, F., Burgold, T., Doni, M., Rosato, U., Amati, B. B., & Testa, G. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.007 · Cited by 88

Senescent cells are resistant to death despite low Bcl-2 level

Sasaki, M., Kumazaki, T., Takano, H., Nishiyama, M., & Mitsui, Y. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00281-0 · Cited by 88

MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer

Calcagno, D. Q., Freitas, V. M., Leal, M. F., de Souza, C. R. T., Demachki, S., Montenegro, R. C., de Assumpção, P. P., Khayat, A. S., Smith, M. D. A. C., Ribeiro‐dos‐Santos, Â., et al. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-141 · Cited by 88

A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation

Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90

The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress

Mendrysa, S. M., & Perry, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2023-2030.2000 · Cited by 87

Integrity of the N‐terminal transcription domain of p53 is required for mutant p53 interference with drug‐induced apoptosis

Matas, D., Sigal, A., Stambolsky, P., Milyavsky, M., Weisz, L., Schwartz, D., Goldfinger, N., & Rotter, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4163 · Cited by 88

Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance

Campaner, S., & Amati, B. B. (2012) · Cell Division · doi:10.1186/1747-1028-7-6 · Cited by 88

From p63 to p53 across p73

Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87

Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis

Hurlin, P. J., Zhou, Z., Toyo‐oka, K., Ota, S., Walker, W. L., Hirotsune, S., & Wynshaw-Boris, A. J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg442 · Cited by 86

The RING domain of Mdm2 can inhibit cell proliferation.

Dang, J., Kuo, M.-L., Eischen, C. M., Stepanova, L., Sherr, C. J., & Roussel, M. F. (2002) · PubMed · Cited by 86

Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis

Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85

Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes

Abreu, R. D. S., Sánchez-Díaz, P. C., Vogel, C., Burns, S. C., Ko, D., Burton, T. L., Vo, D. T., Chennasamudaram, S., Le, S., Shapiro, B. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809605200 · Cited by 87

c-Fos Is a Mediator of the c-Myc-induced Apoptotic Signaling in Serum-deprived Hepatoma Cells via the p38 Mitogen-activated Protein Kinase Pathway

Kalra, N., & Kumar, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400932200 · Cited by 85

Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma

Hogan, C., Hutchison, C., Marcar, L., Milne, D., Saville, M. K., Goodlad, J. R., Kernohan, N., & Meek, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709695200 · Cited by 86

Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion

Guo, F., & Zheng, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207752 · Cited by 88

p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo

Tolbert, D., Lu, X., Yin, C., Tantama, M., & Dyke, T. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.370-377.2002 · Cited by 85

c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle

Adachi, S., Obaya, Á. J., Han, Z., RAMOS‐DeSIMONE, N., Wyche, J. H., & Sedivy, J. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.4929-4937.2001 · Cited by 85

Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc

Sumi, T., Tsuneyoshi, N., Nakatsuji, N., & Suemori, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210353 · Cited by 84

Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer

Kim, J., Eltoum, I., Roh, M., Wang, J., & Abdulkadir, S. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000542 · Cited by 88

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

Ko, A., Han, S. Y., Choi, C. H., Cho, H., Lee, M.-S., Kim, S., Song, J. S., Hong, K., Lee, H., Hewitt, S. M., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0072-0 · Cited by 85

Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc

Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 85

Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.

Hassan, A. B., & Howell, J. A. (2000) · PubMed · Cited by 83

The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity

El‐Athman, R., Генов, Н., Mazuch, J., Zhang, K., Yu, Y., Fuhr, L., Abreu, M., Li, Y., Wallach, T. E., Kramer, A., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002940 · Cited by 84

p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways

Kelly‐Spratt, K. S., Gurley, K. E., Yasui, Y., & Kemp, C. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020242 · Cited by 84

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

Gamble, L. D., Kees, U. R., Tweddle, D. A., & Lunec, J. (2011) · Oncogene · doi:10.1038/onc.2011.270 · Cited by 87

Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B

Ma, Z.-Q., Chua, S. S., DeMayo, F. J., & Tsai, S. Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202809 · Cited by 82

The MYC-Associated Protein CDCA7 Is Phosphorylated by AKT To Regulate MYC-Dependent Apoptosis and Transformation

Gill, R. M., Gabor, T. V., Couzens, A. L., & Scheid, M. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00276-12 · Cited by 81

Pleiotropy of Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Self-Renewal of Embryonic Stem Cells from Refractory Mouse Strains

Ye, S., Tan, L., Yang, R., Fang, B., Qu, S., Schulze, E. N., Song, H., Ying, Q., & Li, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035892 · Cited by 80

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance

Unni, A. M., Bondar, T., & Medzhitov, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 83

E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.

Elliott, M. J., Dong, Y., Yang, H., & McMasters, K. M. (2001) · PubMed · Cited by 80

The INK4A/ARF Locus: Role in Cell Cycle Control and Apoptosis and Implications for Glioma Growth

Ivanchuk, S. M., Mondal, S., Dirks, P. B., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010632309113 · Cited by 81

The Mdm network and its regulation of p53 activities: a rheostat of cancer risk

Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79

Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases

Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79

Regulation of Pluripotency and Self- Renewal of ESCs through Epigenetic- Threshold Modulation and mRNA Pruning

Jia, J., Zheng, X., Hu, G., Cui, K., Zhang, J., Zhang, A., Jiang, H., Lu, B., Yates, J. R., Liu, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.023 · Cited by 84

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo

Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 82

Neurofibromin, a Tumor Suppressor in the Nervous System

Zhu, Y., & Parada, L. F. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5138 · Cited by 79

p53-Induced Apoptosis as a Safeguard against Cancer

Asker, C., Wiman, K. G., & Selivanova, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1446 · Cited by 79

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma

Grønbæk, K., Brown, P. D. N., Møller, M. B., Nedergaard, T., Ralfkiaer, E. M., Mӧller, P., Zeuthen, J., & Guldberg, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401901 · Cited by 79

Cross-talk between the p38α and JNK MAPK Pathways Mediated by MAP Kinase Phosphatase-1 Determines Cellular Sensitivity to UV Radiation

Staples, C. J., Owens, D. M., Maier, J. V., Cato, A. C. B., & Keyse, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117911 · Cited by 79

BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues

Muthalagu, N., Junttila, M. R., Wiese, K. E., Wolf, E., Morton, J. P., Bauer, B., Evan, G. I., Eilers, M., & Murphy, D. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.057 · Cited by 82

Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage

Gewirtz, D. A. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006414422919 · Cited by 78

Omomyc expression in skin prevents Myc-induced papillomatosis

Soucek, L., Nasi, S., & Evan, G. I. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401443 · Cited by 77

Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator

Zhou, X. Y., Hao, Q., Liao, P., Luo, S., Zhang, M., Hu, G., Liu, H., Zhang, Y.-W., Cao, B., Baddoo, M., et al. (2016) · eLife · doi:10.7554/elife.15099 · Cited by 84

Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts

Lindström, M. S., & Wiman, K. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206659 · Cited by 77

Developmental defects and tumor predisposition in Rb mutant mice

Vooijs, M., & Berns, A. J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202999 · Cited by 77

Oncoapoptotic signaling and deregulated target genes in cancers: Special reference to oral cancer

Khan, Z., & Bisen, P. S. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.002 · Cited by 78

What have animal models taught us about the p53 pathway?

Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78

Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation

Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 76

Immunolocalization of Human p14ARF to the Granular Component of the Interphase Nucleolus

Lindström, M. S., Klangby, U., Inoue, R., Pisa, P., Wiman, K. G., & Asker, C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4854 · Cited by 77

30 years and a long way into p53 research

Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 80

MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation

Jackson, M. W., Lindström, M. S., & Berberich, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010685200 · Cited by 74

Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF–p53 pathway

Nagao, M., Campbell, K., Burns, K. A., Kuan, C.-Y., Trumpp, A., & Nakafuku, M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200807130 · Cited by 75

Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways

Weber, H. O., Samuel, T., Rauch, P., & Funk, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205429 · Cited by 74

RNA Helicase DDX5 Is a p53-Independent Target of ARF That Participates in Ribosome Biogenesis

Saporita, A. J., Chang, H., Winkeler, C. L., Apicelli, A. J., Kladney, R. D., Wang, J., Townsend, R. R., Michel, L. S., & Weber, J. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1472 · Cited by 74

Obligate Roles for p16 Ink4a and p19 Arf -p53 in the Suppression of Murine Pancreatic Neoplasia

Bardeesy, N. M., Morgan, J. A., Sinha, M., Signoretti, S., Srivastava, S., Loda, M. F., Merlino, G. T., & DePinho, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.635-643.2002 · Cited by 74

The p53 tumor suppressor: Critical regulator of life & death in cancer

Fisher, D. E. (2001) · APOPTOSIS · doi:10.1023/a:1009659708549 · Cited by 74

Identification of Small Molecule Activators of BMP Signaling

Vrijens, K., Lin, W., Cui, J., Farmer, D. M., Low, J. A., Pronier, E., Zeng, F.-Y., Shelat, A. A., Guy, R. K., Taylor, M. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059045 · Cited by 73

Aberrant ubiquitin-mediatedproteolysis of cell cycle regulatory proteins and oncogenesis

Bashir, T., & Pagano, M. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88305-7 · Cited by 73

Reversible Kinetic Analysis of Myc Targets In vivo Provides Novel Insights into Myc-Mediated Tumorigenesis

Lawlor, E. R., Soucek, L., Swigart, L. B., Shchors, K., Bialucha, C. U., & Evan, G. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3826 · Cited by 74

Apoptosis and chemoresistance in transgenic cancer models

Schmitt, C. A., & Lowe, S. W. (2001) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0293-3 · Cited by 74

p53-Dependent Transcription and Tumor Suppression Are Not Affected in Set7/9-Deficient Mice

Lehnertz, B., Rogalski, J. C., Schulze, F. M., Yi, L., Lin, S., Kast, J., & Rossi, F. M. V. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.006 · Cited by 72

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome–positive acute lymphoblastic leukemia

Boulos, N., Mulder, H. L., Calabrese, C. R., Morrison, J. B., Rehg, J. E., Relling, M. V., Sherr, C. J., & Williams, R. T. (2011) · Blood · doi:10.1182/blood-2010-08-301267 · Cited by 72

Macrophage Migration Inhibitory Factor Deficiency Is Associated with Altered Cell Growth and Reduced Susceptibility to Ras-mediated Transformation

Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 72

Human Cytomegalovirus IE1-72 Activates Ataxia Telangiectasia Mutated Kinase and a p53/p21-Mediated Growth Arrest Response

Castillo, J., Frame, F. M., Rogoff, H. A., Pickering, M., Yurochko, A. D., & Kowalik, T. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11467-11475.2005 · Cited by 72

Myc: The Beauty and the Beast

Wasylishen, A. R., & Penn, L. Z. (2010) · Genes & Cancer · doi:10.1177/1947601910378024 · Cited by 77

Whole-Body Sleeping Beauty Mutagenesis Can Cause Penetrant Leukemia/Lymphoma and Rare High-Grade Glioma without Associated Embryonic Lethality

Collier, L. S., Adams, D. J., Hackett, C. S., Bendzick, L. E., Akagi, K., Davies, M. N., Diers, M. D., Rodríguez, F. J., Bender, A. M., Tieu, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1760 · Cited by 71

Cdk2: a key regulator of the senescence control function of Myc

Hydbring, P., & Larsson, L. (2010) · Aging · doi:10.18632/aging.100140 · Cited by 71

DNA damage, p14ARF, Nucleophosmin (NPM/B23), and cancer

Gjerset, R. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9040-y · Cited by 71

ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc

Russell, J. L., Powers, J. T., Rounbehler, R. J., Rogers, P. M., Conti, C. J., & Johnson, D. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1360-1368.2002 · Cited by 72

Acceleration of Gastric Tumorigenesis Through MKRN1-Mediated Posttranslational Regulation of p14ARF

Ko, A., Shin, J.-Y., Seo, J., Lee, K.-D., Lee, E., Lee, M.-S., Lee, H., Choi, I. J., Jeong, J. S., Chun, K., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs424 · Cited by 71

Quantitative Proteomic Analysis of Myc-induced Apoptosis

Shiio, Y., Suh, K. S., Lee, H., Yuspa, S. H., Eisenman, R. N., & Aebersold, R. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509349200 · Cited by 71

Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis

Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 71

pRb and E2f-1 in mouse development and tumorigenesis

Macleod, K. F. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80005-7 · Cited by 70

Mdmx promotes genomic instability independent of p53 and Mdm2

Carrillo, A. M., Bouska, A., Arrate, M. P., & Eischen, C. M. (2015) · Oncogene · doi:10.1038/onc.2014.27 · Cited by 69

ARF tumor suppression in the nucleolus

Maggi, L. B., Winkeler, C. L., Miceli, A. P., Apicelli, A. J., Brady, S. N., Kuchenreuther, M., & Weber, J. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.016 · Cited by 73

A Novel c-Myc- responsive Gene, JPO1, Participates in Neoplastic Transformation

Prescott, J. E., Osthus, R. C., Lee, L. A., Lewis, B. C., Shim, H., Barrett, J. F., Guo, Q. M., Hawkins, A. L., Griffin, C. A., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107357200 · Cited by 69

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis

Aprelikova, O. N., Chen, K., Touny, L. H. E., Brignatz, C., Han, J. S., Qiu, T., Yang, H. H., Lee, M. P., Zhu, M., & Green, J. E. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0205-6 · Cited by 69

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis

Maerken, T. V., Vandesompele, J., Rihani, A., Paepe, A. D., & Speleman, F. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.138 · Cited by 74

The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19 ARF

Seavey, S. E., Holubar, M. K., Saucedo, L. J., & Perry, M. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7590-7598.1999 · Cited by 69

A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress.

Stepanova, L., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-06-2242 · Cited by 68

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy

Kung, C.-P., & Weber, J. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.818744 · Cited by 71

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma

Frank, A. J., Hernán, R., Hollander, A. B., Lindsey, J. C., Lusher, M. E., Fuller, C. E., Clifford, S. C., & Gilbertson, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.016 · Cited by 68

Rsf-1, a Chromatin Remodeling Protein, Induces DNA Damage and Promotes Genomic Instability

Sheu, J. J., Guan, B., Choi, J., Lin, A. W., Lee, C., Hsiao, Y.-T., Wang, T., Tsai, F., & Shih, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138735 · Cited by 67

Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo

Balsitis, S. J., Dick, F. A., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N. J., & Lambert, P. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11392-11402.2005 · Cited by 67

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas

Dolcetti, R., Col, J. D., Martorelli, D., Carbone, A., & Klein, E. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.07.005 · Cited by 66

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819

Regulation of Myc function by ARF: Checkpoint for Myc-induced oncogenesis

Sarkar, D., & Fisher, P. B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.6.2939 · Cited by 6

Abstract A40: Investigating the functional response of the ARF tumor suppressor to acute p53 loss

Forys, J. T., Kladney, R. D., & Weber, J. D. (2011) · Cancer Research · doi:10.1158/1538-7445.fbcr11-a40

p19ARF directly and differentially controls the functions of c-Myc independently of p53

Qi, Y., Gregory, M. A., Li, Z., Brousal, J. P., West, K. A., & Hann, S. (2004) · Nature · doi:10.1038/nature02958 · Cited by 214

Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc

Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39